Is Desmopressin FDA approved?

Desmopressin is FDA approved (FDA status current as of 1978-01-01). This regulatory status is provided for research and educational context only.

Is Leu-Enkephalin FDA approved?

Leu-Enkephalin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Desmopressin administered in research settings?

In research settings, Desmopressin is typically administered via the intranasal, oral, or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

How is Leu-Enkephalin administered in research settings?

In research settings, Leu-Enkephalin is typically administered via the subcutaneous or intranasal routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Desmopressin vs Leu-Enkephalin

Peptide Comparison

Desmopressin vs Leu-Enkephalin

Q: What is the difference between Desmopressin and Leu-Enkephalin?

Desmopressin: Synthetic vasopressin analogue (V2R selective); crosses blood-brain barrier; enhances hippocampal LTP and memory consolidation; longer-acting than natural vasopressin Leu-Enkephalin: Binds delta and mu opioid receptors in the CNS and periphery. Modulates pain signal transmission in dorsal horn neurons.

Both are Neuro & Cognitive peptides.

Desmopressin

DDAVP

CognitiveFDA ApprovedPrescription

Half-life: 1.5-2.5 hours (intranasal)

2 providers listed

Full Desmopressin profile →

Leu-Enkephalin

Leucine enkephalin

RecoveryNot EvaluatedResearch Only

No providers listed yet

Full Leu-Enkephalin profile →

Bottom line

Desmopressin is FDA-approved, while Leu-Enkephalin is not evaluated — the clearest structural difference between them.

Quick Verdict

Desmopressin

Evidence

Clinical

Half-life

1.5-2.5 hours (intranasal)

Leu-Enkephalin

Evidence

Observational

Half-life

—

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Desmopressin
Further along in FDA review	Desmopressin
Oral administration option	Desmopressin
More provider options (2 vs 0)	Desmopressin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Desmopressin

Leu-Enkephalin

Mechanism Family

Neuro & Cognitive

Half-life

1.5-2.5 hours (intranasal)

—

FDA Status

approved

not evaluated

Admin Routes

intranasal, oral, subcutaneous

subcutaneous, intranasal

Availability

Prescription

Research Only

Providers

2 listed

None listed

FDA Update

Jan 1978

—

Avail. Notes

FDA-approved synthetic vasopressin analog. Brands: DDAVP (NDA 017922), Stimate, Nocdurna (NDA 201532, Jun 2018). Approved forms: injection, intranasal, oral, sublingual. Prescription only.

—

Research Evidence

Desmopressin

ClinicalRCT · 7 key studies · most recent 2026

Leu-Enkephalin

ObservationalCohort study · 2 key studies · most recent 2026

Research Citations

Desmopressin

Cohort2026 · BMC Nephrol

Proactive desmopressin for the prevention of serum sodium overcorrection in moderate-to-severe hyponatremia:…

Cohort2026 · Clinical Endocrinology

Clinical Outcomes Following Supply-Driven Transition From Intranasal to Oral Desmopressin in AVP-Deficiency

Cohort2026 · Int J Urol

Nationwide Trends in Desmopressin Prescribing for Nocturnal Polyuria in Japan: A Population-Based Analysis (2…

Cohort2026 · J Pediatr Hematol Oncol

Bleeding Phenotypes in Inherited Platelet Function Disorders: Insights From the ATHNdataset.

+3 more

Leu-Enkephalin

Cohort2026 · Drug Deliv Transl Res

Combining Leu-enkephalin nanomedicines with enkephalinase inhibitors: a promising painkiller strategy?

Animal1986 · Brain Research

Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray m…

About Desmopressin

Synthetic vasopressin analogue (V2R selective); crosses blood-brain barrier; enhances hippocampal LTP and memory consolidation; longer-acting than natural vasopressin

Research Areas

memory consolidationlearning enhancementantidiuretichemostasis

About Leu-Enkephalin

Binds delta and mu opioid receptors in the CNS and periphery. Modulates pain signal transmission in dorsal horn neurons. Also activates opioid receptors on immune cells, influencing cytokine production and immune cell trafficking.

Research Areas

pain modulationanti-inflammatoryimmune modulation

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Desmopressin

Reported (Unverified — Pending Clinical Review)

hyponatremiaheart failureuncontrolled hypertensionpsychogenic polydipsia

No established clinical contraindications

Suggested Monitoring

Under clinical review

Being verified by our medical team before we display monitoring guidance for this peptide.

Leu-Enkephalin

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Find Providers

Where to source these peptides

Providers offering

Desmopressin

2 listed

Browse directory →

Providers offering

Leu-Enkephalin

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.